North Chicago, United States
AbbVie, founded in 2013, is a prominent player in the global biopharmaceutical sector. The company's slogan underscores its commitment to discovering, developing, and marketing both biopharmaceuticals and small molecule drugs, aiming to tackle complex health issues in its core areas of immunology, oncology, neuroscience, eye care, and aesthetics.
Based in the United States, AbbVie differentiates itself by placing a strong emphasis on creating impactful solutions not just for patients, but also for communities worldwide. As an established entity within the Biotechnology, Health Care, and Pharmaceutical industries, AbbVie continues to leverage its expertise and resources to address areas of unmet medical need.
The company's last significant financial movement involved a $7.50B post-IPO debt investment on 01 February 2026. This robust financial position signals confidence in its strategic direction and potential for sustainable growth, making AbbVie an attractive prospect for investors looking to enter or expand in the thriving healthcare market.
